Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-18 Sale | 2026-05-18 4:52 pm | SOLENO THERAPEUTICS INC | SLNO | Yen Kristen SEE REMARKS | 37,639 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:49 pm | SOLENO THERAPEUTICS INC | SLNO | Volck Birgitte Director | 17,536 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:47 pm | SOLENO THERAPEUTICS INC | SLNO | Sinclair Andrew Director | 10,491 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:44 pm | SOLENO THERAPEUTICS INC | SLNO | Pauls Matthew Director | 10,491 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:42 pm | SOLENO THERAPEUTICS INC | SLNO | Norrett Kevin Chief Business Officer | 17,786 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:41 pm | SOLENO THERAPEUTICS INC | SLNO | Manning Meredith Chief Commercial Officer | 64,507 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:39 pm | SOLENO THERAPEUTICS INC | SLNO | Joshi Manher Chief Development Officer | 20,171 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:38 pm | SOLENO THERAPEUTICS INC | SLNO | Huang Michael F. Sr. VP of Clinical Development | 39,823 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:36 pm | SOLENO THERAPEUTICS INC | SLNO | Hirano Patricia C SEE REMARKS | 22,702 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:34 pm | SOLENO THERAPEUTICS INC | SLNO | Hahn Mark W Director | 10,046 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:32 pm | SOLENO THERAPEUTICS INC | SLNO | Fulk Jennifer CHIEF FINANCIAL OFFICER | 39,200 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:29 pm | SOLENO THERAPEUTICS INC | SLNO | Bir Dawn Carter Director | 16,991 | $0 | $0 | 0 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 4:27 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 583,656 | $0 | $0 | 0 (Direct) | View |
| 2026-03-27 Sale | 2026-03-31 8:17 pm | SOLENO THERAPEUTICS INC | SLNO | Manning Meredith Chief Commercial Officer | 7,522 | $30.44 | $228,980 | 64,507 (Direct) | View |
| 2026-03-27 Sale | 2026-03-31 8:15 pm | SOLENO THERAPEUTICS INC | SLNO | Huang Michael F. Sr. VP of Clinical Development | 6,582 | $30.44 | $200,365 | 39,823 (Direct) | View |
| 2025-07-01 Sale | 2025-07-03 4:41 pm | SOLENO THERAPEUTICS INC | SLNO | Hirano Patricia C SEE REMARKS | 3,830 | $82.76 | $316,971 | 13,206 (Direct) | View |
| 2025-06-24 Sale | 2025-06-26 6:04 pm | SOLENO THERAPEUTICS INC | SLNO | Hirano Patricia C SEE REMARKS | 266 | $84.25 | $22,411 | 17,036 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-02 Option Award | 2026-03-04 5:59 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Fulk Jennifer CHIEF FINANCIAL OFFICER | 39,200 | $0 | 106,860 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-04 5:59 pm | N/A 2036-03-02 | SOLENO THERAPEUTICS INC | SLNO | Fulk Jennifer CHIEF FINANCIAL OFFICER | 67,660 | $0 | 106,860 (Direct) | View |
| 2026-01-21 Option Award | 2026-01-23 6:08 pm | N/A 2036-01-21 | SOLENO THERAPEUTICS INC | SLNO | Yen Kristen SEE REMARKS | 22,300 | $0 | 49,539 (Direct) | View |
| 2026-01-21 Option Award | 2026-01-23 6:07 pm | N/A 2036-01-21 | SOLENO THERAPEUTICS INC | SLNO | Norrett Kevin Chief Business Officer | 7,500 | $0 | 21,786 (Direct) | View |
| 2026-01-21 Option Award | 2026-01-23 6:06 pm | N/A 2036-01-21 | SOLENO THERAPEUTICS INC | SLNO | Manning Meredith Chief Commercial Officer | 61,400 | $0 | 104,829 (Direct) | View |
| 2026-01-21 Option Award | 2026-01-23 6:05 pm | N/A 2036-01-21 | SOLENO THERAPEUTICS INC | SLNO | Mackaness James H CHIEF FINANCIAL OFFICER | 61,400 | $0 | 164,563 (Direct) | View |
| 2026-01-21 Option Award | 2026-01-23 6:04 pm | N/A 2036-01-21 | SOLENO THERAPEUTICS INC | SLNO | Joshi Manher Chief Development Officer | 8,800 | $0 | 24,871 (Direct) | View |
| 2026-01-21 Option Award | 2026-01-23 6:02 pm | N/A 2036-01-21 | SOLENO THERAPEUTICS INC | SLNO | Huang Michael F. Sr. VP of Clinical Development | 22,300 | $0 | 58,305 (Direct) | View |
| 2026-01-21 Option Award | 2026-01-23 6:01 pm | N/A 2036-01-21 | SOLENO THERAPEUTICS INC | SLNO | Hirano Patricia C SEE REMARKS | 22,300 | $0 | 34,602 (Direct) | View |
| 2026-01-21 Option Award | 2026-01-23 6:00 pm | N/A 2036-01-21 | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 245,600 | $0 | 715,056 (Direct) | View |
| 2025-12-15 Tax Withholding | 2025-12-17 4:39 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Yen Kristen SEE REMARKS | 904 | $49.95 | 27,239 (Direct) | View |
| 2025-12-15 Tax Withholding | 2025-12-17 4:38 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Manning Meredith Chief Commercial Officer | 1,922 | $49.95 | 43,429 (Direct) | View |
| 2025-12-15 Tax Withholding | 2025-12-17 4:37 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Mackaness James H CHIEF FINANCIAL OFFICER | 2,013 | $49.95 | 103,163 (Direct) | View |
| 2025-12-15 Tax Withholding | 2025-12-17 4:36 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Huang Michael F. Sr. VP of Clinical Development | 812 | $49.95 | 36,005 (Direct) | View |
| 2025-12-15 Tax Withholding | 2025-12-17 4:35 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Hirano Patricia C SEE REMARKS | 904 | $49.95 | 12,302 (Direct) | View |
| 2025-12-15 Gift | 2025-12-17 4:34 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 100,000 | $0 | 469,456 (Direct) | View |
| 2025-12-15 Tax Withholding | 2025-12-17 4:34 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 7,620 | $49.95 | 469,456 (Direct) | View |
| 2025-11-17 Option Award | 2025-11-19 6:49 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Norrett Kevin Chief Business Officer | 14,286 | $0 | 78,572 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 6:49 pm | N/A 2035-11-17 | SOLENO THERAPEUTICS INC | SLNO | Norrett Kevin Chief Business Officer | 64,286 | $0 | 78,572 (Direct) | View |
| 2025-11-10 Option Award | 2025-11-12 5:21 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Joshi Manher Chief Development Officer | 16,071 | $0 | 88,392 (Direct) | View |
| 2025-11-10 Exercise | 2025-11-12 5:21 pm | N/A 2035-11-10 | SOLENO THERAPEUTICS INC | SLNO | Joshi Manher Chief Development Officer | 72,321 | $0 | 88,392 (Direct) | View |
| 2025-10-13 Option Award | 2025-10-14 4:23 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Hahn Mark W Director | 10,046 | $0 | 10,046 (Direct) | View |
| 2025-06-24 Exercise | 2025-06-26 6:04 pm | N/A 2027-04-19 | SOLENO THERAPEUTICS INC | SLNO | Hirano Patricia C SEE REMARKS | 266 | $0 | 17,036 (Direct) | View |
| 2025-06-24 Exercise | 2025-06-26 6:04 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Hirano Patricia C SEE REMARKS | 266 | $44.25 | 17,036 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 7:27 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Volck Birgitte Director | 3,991 | $0 | 17,536 (Direct) | View |